Overview

A Long-term Safety Study of QVM149 in Japanese Patients With Asthma

Status:
Completed
Trial end date:
2019-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide long term safety data of QVM149 in Japanese patients with asthma for the registration of QVM149 in Japan.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals